Javascript must be enabled to continue!
Ribozymes as Therapeutic Agents against Infectious Diseases
View through CrossRef
Ribozymes, also known as RNA enzymes, are catalytic RNA molecules capable of cleaving specific RNA sequences, leading to decreased expression of targeted genes. Recent studies suggest their role in cancer therapeutics, genetic diseases and retroviral infections. This book chapter will focus on ribozymes acting as therapeutic agents against infectious diseases caused by viral and bacterial pathogens. Firstly, we will introduce a brief history of ribozymes and a general overview of ribozymes and their characteristics. Next, different types of ribozymes will be explored regarding their targets and mechanisms of action. After that, ribozymes specific to viral and bacterial infections will be explored. We will briefly discuss the current status of ribozymes as therapeutic agents. Finally, the roadblock and challenges ribozymes face before being developed into therapeutic agents—such as their delivery and efficacy issues—will be discussed.
Title: Ribozymes as Therapeutic Agents against Infectious Diseases
Description:
Ribozymes, also known as RNA enzymes, are catalytic RNA molecules capable of cleaving specific RNA sequences, leading to decreased expression of targeted genes.
Recent studies suggest their role in cancer therapeutics, genetic diseases and retroviral infections.
This book chapter will focus on ribozymes acting as therapeutic agents against infectious diseases caused by viral and bacterial pathogens.
Firstly, we will introduce a brief history of ribozymes and a general overview of ribozymes and their characteristics.
Next, different types of ribozymes will be explored regarding their targets and mechanisms of action.
After that, ribozymes specific to viral and bacterial infections will be explored.
We will briefly discuss the current status of ribozymes as therapeutic agents.
Finally, the roadblock and challenges ribozymes face before being developed into therapeutic agents—such as their delivery and efficacy issues—will be discussed.
Related Results
RNA reprogramming of α‐mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes
RNA reprogramming of α‐mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes
Trans‐splicing group I ribozymes have been introduced in order to mediate RNA reprogramming (including RNA repair) of therapeutically relevant RNA transcripts. Efficient RNA reprog...
Mapping the Conformational Landscape of the Neutral Network of RNA Sequences That Connect Two Functional Distinctly Different Ribozymes
Mapping the Conformational Landscape of the Neutral Network of RNA Sequences That Connect Two Functional Distinctly Different Ribozymes
AbstractDuring evolution of an RNA world, the development of enzymatic function was essential. Such enzymatic function was linked to RNA sequences capable of adopting specific RNA ...
Direct testing of natural twister ribozymes from over a thousand organisms reveals a broad tolerance for structural imperfections
Direct testing of natural twister ribozymes from over a thousand organisms reveals a broad tolerance for structural imperfections
ABSTRACT
Twister ribozymes are an extensively studied class of nucleolytic RNAs. Thousands of natural twisters have been proposed using sequence ...
Regards sur les ribozymes
Regards sur les ribozymes
Derrière le néologisme « ribozymes » se cache une famille de molécules fascinantes, des ribo-enzymes, pourtant relativement peu étudiées. Ces ARN doués d’activité catalytique sont ...
Network of Intelligent Agents
Network of Intelligent Agents
Any problem-solving can be modelled by actions or methods by which from resources or data, one agent makes an action to obtain a result or arrive at a task. A network of actions ca...
Statistical simulations of infectious diseases in Southwestern Nigeria (A case study of Ekiti and Oyo State)
Statistical simulations of infectious diseases in Southwestern Nigeria (A case study of Ekiti and Oyo State)
This study adopts Markov chain to simulate some infectious diseases in two States (Ekiti and Oyo) of southwestern Nigeria, to describe the situations where the outcome of infectiou...
PocketAID: The Pocket Atlas of Infectious Diseases Mobile Application
PocketAID: The Pocket Atlas of Infectious Diseases Mobile Application
ObjectiveThe Pocket Atlas of Infectious Diseases (PocketAID) mobile application developed at Pacific Northwest National Laboratory (PNNL) provides infectious disease education and ...
Development, reliability and validity of infectious disease specialist Nurse’s Core competence scale
Development, reliability and validity of infectious disease specialist Nurse’s Core competence scale
Abstract
Aim
This study aims to develop an instrument to measure infectious disease specialist nurses’ core competence an...

